Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1550 of 2228 entries
View as:

ADAM-Afatinib Diarrhea Assessment and Management

Phase: N/A Priority: Normal
NCT ID: NCT01814553 Org: User:
Start: 04/30/13 End: 07/31/15 Due: 07/31/16

Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02171455 Org: User:
Start: 01/31/06 End: - Due: -

Dose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02253927 Org: User:
Start: 05/31/06 End: - Due: -

A Study to Test How Different Doses of BI 1015550 Are Taken up in the Body of Healthy Japanese Men

Phase: N/A Priority: Normal
NCT ID: NCT06139302 Org: User:
Start: 12/20/23 End: 02/13/24 Due: 02/13/25

Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

Phase: N/A Priority: Normal
NCT ID: NCT00879411 Org: User:
Start: 04/30/09 End: - Due: -

A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03123120 Org: User:
Start: 06/07/17 End: 09/16/20 Due: 09/16/21

Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential

Phase: N/A Priority: Normal
NCT ID: NCT02183285 Org: User:
Start: 11/30/03 End: - Due: -

Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00752388 Org: User:
Start: 11/30/08 End: - Due: -

A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Midazolam in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT05550636 Org: User:
Start: 10/11/22 End: 12/16/22 Due: 12/16/23

Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered Twice Daily Orally to Healthy Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02211144 Org: User:
Start: 03/31/02 End: - Due: -

OTIVACTO Regional Center Vienna (RCV) Non-Interventional Study (NIS)

Phase: N/A Priority: Normal
NCT ID: NCT02719639 Org: User:
Start: 04/01/16 End: 05/31/17 Due: 05/31/18

Drug Drug Interaction of BI 201335 and Tenofovir

Phase: N/A Priority: Normal
NCT ID: NCT01340196 Org: User:
Start: 04/30/11 End: - Due: -

Preference Tiotropium Respimat Study in COPD

Phase: N/A Priority: Normal
NCT ID: NCT01810692 Org: User:
Start: 03/31/13 End: 03/31/14 Due: 03/31/15

Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00376623 Org: User:
Start: 07/25/06 End: 04/01/08 Due: 04/01/09

Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00662740 Org: User:
Start: 04/15/08 End: 11/21/08 Due: 11/21/09

BI 443651 Multiple Rising Dose in Healthy Volunteers Followed by a Cross-over in CF Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02976519 Org: User:
Start: 02/15/17 End: 08/29/18 Due: 08/29/19

Treatment Pattern of Oral Anticoagulants (OAC) in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02982863 Org: User:
Start: 12/01/16 End: 12/01/16 Due: 12/01/17

Excretion Balance of 14c-radiolabeled BIRB 796 BS in Normal Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02211885 Org: User:
Start: 10/31/02 End: - Due: -

GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutations

Phase: N/A Priority: Normal
NCT ID: NCT02047903 Org: User:
Start: 03/05/14 End: 12/31/18 Due: 12/31/19

Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)

Phase: N/A Priority: Normal
NCT ID: NCT00617019 Org: User:
Start: 09/30/06 End: - Due: -

A Study in Healthy Men to Test How BI 685509 is Processed in the Body

Phase: N/A Priority: Normal
NCT ID: NCT05515328 Org: User:
Start: 09/08/22 End: 11/17/22 Due: 11/17/23

Bioequivalence of Pramipexole Extended Release (PPX ER) 1.5mg x 1 Tablet Once Daily (q.d.) vs. PPX ER 0.375mg x 4 Tablets Under Fasted and Fed Conditions in Japanese Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01119443 Org: User:
Start: 04/30/10 End: - Due: -

A Study in Healthy Men to Test How Esomeprazole Influences the Amount of BI 1819479 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT05467475 Org: User:
Start: 10/18/22 End: 01/23/23 Due: 01/23/24

Single Rising Dose Study of BI 655088 Administered Intravenously in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02696616 Org: User:
Start: 03/16/16 End: 02/14/19 Due: 02/14/20

DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril

Phase: N/A Priority: Normal
NCT ID: NCT00274118 Org: User:
Start: 07/31/97 End: 01/31/04 Due: 01/31/05